Progress has been slow in reversing rates of opioid misuse and overdose since the epidemic was declared a national public health emergency in October 2017. This is largely due to the complex catalysts of the crisis and the intersecting strategies that will be required to resolve them.
To improve collaboration and accelerate the pace of change, the National Academy of Medicine (NAM) has partnered with the Aspen Institute and more than 50 other organizations to form an Action Collaborative on Countering the U.S. Opioid Epidemic. The Action Collaborative comprises four working groups that address key issues in formulating a comprehensive response to the opioid epidemic: education and training; prescribing guidelines and evidence standards; prevention, treatment, and recovery; and research, data, and metrics. AACOM President and CEO Stephen C. Shannon, DO, MPH, is a participant in the education and training working group.
This unique public-private partnership comprises government entities, health systems, communities, provider groups, payers, industry organizations, academia, nonprofits, and others committed to sharing knowledge, aligning ongoing initiatives, and advancing collective, multi-faceted solutions. The Collaborative’s future activities will include expert publications, public meetings, and developing an information hub, among other efforts.
To learn more about the Collaborative, visit the NAM website